Search Results - "Arrazi, J"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia by Craddock, C, Quek, L, Goardon, N, Freeman, S, Siddique, S, Raghavan, M, Aztberger, A, Schuh, A, Grimwade, D, Ivey, A, Virgo, P, Hills, R, McSkeane, T, Arrazi, J, Knapper, S, Brookes, C, Davies, B, Price, A, Wall, K, Griffiths, M, Cavenagh, J, Majeti, R, Weissman, I, Burnett, A, Vyas, P

    Published in Leukemia (01-05-2013)
    “…Epigenetic therapies demonstrate significant clinical activity in acute myeloid leukemia (AML) and myelodysplasia (MDS) and constitute an important new class…”
    Get full text
    Journal Article
  2. 2

    Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT by Pourgheysari, B, Piper, K P, McLarnon, A, Arrazi, J, Bruton, R, Clark, F, Cook, M, Mahendra, P, Craddock, C, Moss, P A H

    Published in Bone marrow transplantation (Basingstoke) (01-06-2009)
    “…Reactivation of CMV is a common complication following allogeneic haematopoietic SCT and is associated with significant morbidity and mortality. The relative…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5